| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.6B | $3.4B | $2.9B | $2.6B | $2.4B | $2.1B | $2.1B | $2.0B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.6B | $0.5B | $0.4B | $0.4B | $0.4B | $0.3B | $0.4B | $0.3B |
| Net Income | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| EPS (Basic) | $2.77 | $3.02 | $2.33 | $2.61 | $2.72 | $1.73 | $2.39 | $2.38 |
| EPS (Diluted) | $2.77 | $3.01 | $2.33 | $2.60 | $2.72 | $1.72 | $2.39 | $2.37 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.2B | $12.5B | $11.2B | $10.5B | $9.5B | $9.1B | $8.4B | $8.1B |
| Current Assets | $1.1B | $1.0B | $0.9B | $1.2B | $0.7B | $0.7B | $0.5B | $0.6B |
| Cash & Equivalents | — | — | — | — | — | — | $0.0B | $0.1B |
| Total Liabilities | $9.1B | $8.8B | $7.9B | $7.7B | $6.8B | $6.5B | $5.8B | $5.6B |
| Current Liabilities | $1.0B | $1.1B | $1.1B | $1.5B | $0.8B | $0.8B | $0.5B | $0.8B |
| Stockholders' Equity | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B | $0.8B | $0.4B | $0.7B | $0.5B | $0.6B | $0.5B | $0.6B |
| Investing Cash Flow | $-1.2B | $-1.3B | $-1.4B | $-0.8B | $-0.7B | $-0.8B | $-0.6B | $-0.5B |
| Capital Expenditures | $1.2B | $1.3B | $1.4B | $0.8B | $0.6B | $0.8B | $0.6B | $0.6B |
| Financing Cash Flow | $0.1B | $0.5B | $0.8B | $0.2B | $-0.1B | $0.4B | $-0.0B | $-0.1B |